Buprenorphine And Naloxone 62756-0970-64
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- July 18, 2017
- Listing Expires
- December 31, 2027
- Application
- ANDA201633
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Selected Package
62756-0970-64Selected3 BLISTER PACK in 1 CARTON (62756-970-64) / 10 TABLET in 1 BLISTER PACK
Other packages for this product(1)
30 TABLET in 1 BOTTLE (62756-970-83)